Huayun Yu

773 total citations
32 papers, 593 citations indexed

About

Huayun Yu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Huayun Yu has authored 32 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Complementary and alternative medicine and 6 papers in Pharmacology. Recurrent topics in Huayun Yu's work include Traditional Chinese Medicine Analysis (6 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Characterization of Pyrroles (3 papers). Huayun Yu is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Asymmetric Synthesis and Catalysis (5 papers) and Synthesis and Characterization of Pyrroles (3 papers). Huayun Yu collaborates with scholars based in China, United States and United Kingdom. Huayun Yu's co-authors include R. Karl Dieter, Shijun Wang, Xuming Ji, Ke Ma, Xiuyang Li, Ningyi Chen, Xianjun Fu, Zhe Zhang, Zulqarnain Baloch and Xiansu Chi and has published in prestigious journals such as Scientific Reports, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Huayun Yu

30 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huayun Yu China 12 224 211 92 80 53 32 593
Guowei Gong China 19 362 1.6× 71 0.3× 108 1.2× 94 1.2× 53 1.0× 42 736
Nibha Mishra India 15 201 0.9× 140 0.7× 50 0.5× 23 0.3× 22 0.4× 33 575
Lvjie Xu China 13 219 1.0× 53 0.3× 51 0.6× 41 0.5× 28 0.5× 23 472
Jae Wook Lee South Korea 15 330 1.5× 121 0.6× 27 0.3× 67 0.8× 14 0.3× 47 624
Zihua Xu China 17 316 1.4× 113 0.5× 60 0.7× 36 0.5× 14 0.3× 41 677
Kuo‐Tong Liou Taiwan 7 265 1.2× 203 1.0× 92 1.0× 152 1.9× 12 0.2× 8 739
Hong-Yan Guo China 18 322 1.4× 144 0.7× 68 0.7× 28 0.3× 15 0.3× 37 701
Baojian Guo China 16 260 1.2× 47 0.2× 120 1.3× 76 0.9× 30 0.6× 26 674
Ranyao Yang China 15 257 1.1× 56 0.3× 45 0.5× 40 0.5× 35 0.7× 19 602
Qing‐Chun Zhao China 17 320 1.4× 73 0.3× 69 0.8× 69 0.9× 11 0.2× 35 660

Countries citing papers authored by Huayun Yu

Since Specialization
Citations

This map shows the geographic impact of Huayun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huayun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huayun Yu more than expected).

Fields of papers citing papers by Huayun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huayun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huayun Yu. The network helps show where Huayun Yu may publish in the future.

Co-authorship network of co-authors of Huayun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Huayun Yu. A scholar is included among the top collaborators of Huayun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huayun Yu. Huayun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yue, Allen W. Song, Guowei Liu, et al.. (2025). Modulation of netrin-1/DCC signaling pathway by Jiawei Kongsheng Zhenzhong Pill improves synaptic structural plasticity in PSD rats. Journal of Pharmacological Sciences. 157(4). 242–252.
3.
Wang, Tong, Meiyi Liu, Yanan Wang, et al.. (2024). Xiaoer niuhuang qingxin powder alleviates influenza a virus infection by inhibiting the activation of the TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology. 328. 118000–118000. 1 indexed citations
5.
Yu, Huayun, et al.. (2024). Jiawei Kongsheng Zhenzhong Pill: marker compounds, absorption into the serum (rat), and Q-markers identified by UPLC-Q-TOF-MS/MS. Frontiers in Pharmacology. 15. 1328632–1328632. 7 indexed citations
6.
Wang, Jiayun, et al.. (2023). Research on Xiaoyao Powder in the treatment of depression based on epigenetics and quality markers. Frontiers in Neuroscience. 17. 1223451–1223451. 5 indexed citations
7.
Wang, Tong, Yanan Zhang, Yuan Wang, et al.. (2023). Research progress on the mechanism of traditional Chinese medicine regulating intestinal microbiota to combat influenza a virus infection. Virology Journal. 20(1). 260–260. 7 indexed citations
9.
Zhu, Peiyao, Huayun Yu, Kun Zhou, et al.. (2020). 3,3′-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE2 pathway. Journal of Experimental & Clinical Cancer Research. 39(1). 113–113. 44 indexed citations
10.
Song, Xiaotong, Yuan Wang, Qian Chen, et al.. (2020). Zi Shen Huo Luo Formula Prevents Aldosterone‐Induced Cardiomyocyte Hypertrophy and Cardiac Fibroblast Proliferation by Regulating the Striatin‐Mediated MR/EGFR/ERK Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2020(1). 9028047–9028047. 1 indexed citations
12.
Chi, Xiansu, Shijun Wang, Zulqarnain Baloch, et al.. (2019). Research progress on classical traditional Chinese medicine formula Lily Bulb and Rehmannia Decoction in the treatment of depression. Biomedicine & Pharmacotherapy. 112. 108616–108616. 86 indexed citations
13.
Zhang, Yanan, Huayun Yu, Huaxin Wang, et al.. (2019). Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin β1-PI3K-AKT Pathway in Lung Cancer. Journal of Cancer. 10(2). 293–304. 31 indexed citations
14.
Zhang, Yanan, et al.. (2017). Chinese Herbal Medicine Baoyuan Jiedu Decoction Inhibited Muscle Atrophy of Cancer Cachexia through Atrogin‐l and MuRF‐1. Evidence-based Complementary and Alternative Medicine. 2017(1). 6268378–6268378. 8 indexed citations
15.
Ji, Xuming, Guowei Liu, Huayun Yu, et al.. (2015). Wenxia Changfu Formula (温下肠腑方) induces apoptosis of lung adenocarcinoma in a transplanted tumor model of drug-resistance nude mice. Chinese Journal of Integrative Medicine. 22(10). 752–758. 10 indexed citations
16.
Fu, Xianjun, et al.. (2013). Study on the networks of “Nature-Family-Component” of Chinese medicinal herbs based on association rules mining. Chinese Journal of Integrative Medicine. 19(9). 663–667. 7 indexed citations
17.
Yu, Huayun, Zhichun Wu, Xuming Ji, & Shijun Wang. (2012). Study on the molecule mechanism of warming interior of Zingiberis. Zhonghua zhongyiyao zazhi. 27(1). 181–183. 1 indexed citations
18.
Yu, Huayun, et al.. (2012). Effects of Radix aconiti lateralis preparata and Rhizoma zingiberis on energy metabolism and expression of the genes related to metabolism in rats. Chinese Journal of Integrative Medicine. 18(1). 23–29. 21 indexed citations
19.
Ji, Xuming, Heng Liu, Guowei Liu, et al.. (2011). In Vitro and In Vivo inhibitory effect of the combination of Wenxia Changfu Formula (温下肠腑方) with cisplatin in non-small cell lung cancer. Chinese Journal of Integrative Medicine. 17(12). 908–916. 7 indexed citations
20.
Yu, Huayun. (2009). History and Application of Cynanchum Atratum Bunge. Zhonghua zhongyiyao xuekan. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026